Qingxia Xu

434 total citations
35 papers, 314 citations indexed

About

Qingxia Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Qingxia Xu has authored 35 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Qingxia Xu's work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (4 papers). Qingxia Xu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (4 papers). Qingxia Xu collaborates with scholars based in China, United States and Italy. Qingxia Xu's co-authors include Ning Xue, Junhua Zhang, Xiaobin Yao, Yun Gao, Lili Zhou, Yong Shen, Mingyue Sun, Xiu‐E Xu, Chunguang Chen and En‐Min Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Ethnopharmacology.

In The Last Decade

Qingxia Xu

33 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingxia Xu China 11 179 76 41 38 27 35 314
Anupama Modi India 11 166 0.9× 76 1.0× 47 1.1× 22 0.6× 25 0.9× 31 332
Ayyoob Khosravi Iran 9 146 0.8× 51 0.7× 50 1.2× 34 0.9× 46 1.7× 40 297
Ding‐Chao Rong China 7 123 0.7× 46 0.6× 54 1.3× 32 0.8× 33 1.2× 10 329
Ying Peng China 12 158 0.9× 108 1.4× 28 0.7× 34 0.9× 27 1.0× 28 401
Sudharshan Ravi United States 8 167 0.9× 78 1.0× 111 2.7× 41 1.1× 47 1.7× 10 361
Emad Gamil Khidr Egypt 12 245 1.4× 213 2.8× 47 1.1× 43 1.1× 49 1.8× 25 454
Xianfeng Shao China 10 238 1.3× 131 1.7× 27 0.7× 55 1.4× 16 0.6× 27 387
Caroline Snowden United States 6 124 0.7× 41 0.5× 44 1.1× 83 2.2× 12 0.4× 10 344
Chen Shen China 7 136 0.8× 36 0.5× 39 1.0× 47 1.2× 16 0.6× 27 292

Countries citing papers authored by Qingxia Xu

Since Specialization
Citations

This map shows the geographic impact of Qingxia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingxia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingxia Xu more than expected).

Fields of papers citing papers by Qingxia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingxia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingxia Xu. The network helps show where Qingxia Xu may publish in the future.

Co-authorship network of co-authors of Qingxia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingxia Xu. A scholar is included among the top collaborators of Qingxia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingxia Xu. Qingxia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Fang, Zexu Gu, Qingxia Xu, et al.. (2025). Potential of Glycyrrhiza in the prevention of colitis-associated colon cancer. Fitoterapia. 181. 106398–106398. 4 indexed citations
2.
Shen, Yong, Yong Xia, Shiyong Li, et al.. (2025). A large-scale, multi-centre validation study of an AI-empowered blood-based test for multi-cancer early detection. npj Precision Oncology. 9(1). 321–321.
3.
Wang, Maoqing, Xiaorui Wang, Jun Zhang, et al.. (2025). Evaluation of edible and medicinal varieties based on multidimensional quantitative data: A case study of perilla leaf. Journal of Food Composition and Analysis. 140. 107196–107196. 2 indexed citations
4.
Chen, Qingmin, Baohong Yang, Jinchen Li, et al.. (2025). A predictive nomogram for assessing the likelihood of retrieving 12 lymph nodes after rectal cancer surgery: a single-center study. Frontiers in Oncology. 15. 1617058–1617058.
5.
Xu, Qingxia, Jiaguo Yu, Jiale Li, et al.. (2024). Circulating immune cell profile in patients with colorectal cancer. British journal of surgery. 111(7). 1 indexed citations
6.
Guo, Cong, Lianmei Wang, Sha Chen, et al.. (2024). Xiebai San alleviates acute lung injury by inhibiting the phosphorylation of the ERK/Stat3 pathway and regulating multiple metabolisms. Phytomedicine. 128. 155397–155397. 10 indexed citations
7.
Chen, Sha, Peng Sun, Yan Liu, et al.. (2024). Ginkgolides with anti-PAF activity from Ginkgo biloba L.. Fitoterapia. 175. 105915–105915. 5 indexed citations
8.
Xu, Qingxia, Jing Zhang, Jinzhu Jiang, et al.. (2024). Elucidation of anti-pneumonia pharmacodynamic material basis and potential mechanisms of Xiebai San by combining spectrum–efficacy relationship and surface plasmon resonance. Journal of Ethnopharmacology. 335. 118609–118609. 3 indexed citations
9.
Wang, Shuhui, Wenjin Cui, Qingxia Xu, et al.. (2023). Two pyrrole acids isolated from Phyllanthus emblica L. and their bioactivities. Natural Products and Bioprospecting. 13(1). 26–26. 1 indexed citations
10.
Gao, Yun, Xiaobin Yao, Junhua Zhang, et al.. (2023). Circ_UBAP2 exacerbates proliferation and metastasis of OS via targeting miR‐665/miR‐370‐3p/HMGA1 axis. Environmental Toxicology. 39(1). 212–227. 2 indexed citations
11.
Liu, Yanping, Cong Guo, Jun Zhang, et al.. (2023). Quality uniformity evaluation of Babao Dan capsule based on its 14 main chemical compounds and in vitro anti-inflammatory activity. Arabian Journal of Chemistry. 16(11). 105276–105276. 1 indexed citations
12.
Jiang, Yu, Shulin Chen, Yaxian Wu, et al.. (2022). Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma. Cancer Cell International. 22(1). 300–300. 5 indexed citations
13.
Zhang, Jiajia, et al.. (2022). Practical application of European biological variation combined with Westgard Sigma Rules in internal quality control. Clinical Chemistry and Laboratory Medicine (CCLM). 60(11). 1729–1735. 3 indexed citations
14.
Gao, Yun, et al.. (2021). Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR‐497‐5p/HMGA2 axis. Journal of Biochemical and Molecular Toxicology. 35(12). e22921–e22921. 7 indexed citations
15.
Xue, Ning, et al.. (2021). Development and validation of a risk prediction score for patients with nasopharyngeal carcinoma. Cancer Cell International. 21(1). 452–452. 7 indexed citations
16.
He, Xia, Ning Xue, Xiaohua Liu, et al.. (2021). A novel clinical model for predicting malignancy of solitary pulmonary nodules: a multicenter study in chinese population. Cancer Cell International. 21(1). 115–115. 6 indexed citations
18.
Chen, Ching‐Chow, Xiaolin Wang, Xiaochen Xiong, et al.. (2014). Targeting type Iγ phosphatidylinositol phosphate kinase inhibits breast cancer metastasis. Oncogene. 34(35). 4635–4646. 28 indexed citations
19.
Han, Jingyan, et al.. (2014). Clinical and Prognostic Significance of SOX11 in Breast Cancer. Asian Pacific Journal of Cancer Prevention. 15(13). 5483–5486. 15 indexed citations
20.
Zhang, Yongfa, Qingxia Xu, Lian‐Di Liao, et al.. (2013). κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma. Human Pathology. 44(9). 1756–1765. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026